We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
-12.12%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$3.97B
AUM Growth
-$900M
(-18%)
Cap. Flow
-$143M
Cap. Flow
% of AUM
-3.59%
Top 10 Holdings %
Top 10 Hldgs %
21.23%
Holding
969
New
42
Increased
273
Reduced
549
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$21.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.5M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$12.4M |
| 4 |
MSCI
MSCI
|
+$11.6M |
| 5 |
Lamb Weston
LW
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$32.9M |
| 2 |
Home Depot
HD
|
+$22.9M |
| 3 |
JPMorgan Chase
JPM
|
+$10.6M |
| 4 |
Sysco
SYY
|
+$9.6M |
| 5 |
Nike
NKE
|
+$9.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.14% |
| 2 | Healthcare | 14.34% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
826
Centerspace
CSR
$935M
| $117K | ﹤0.01% |
2,298
+470
| +26% | +$25.1K |
|
|
DRNA
827
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $116K | ﹤0.01% |
10,673
+163
| +2% | +$2.14K |
|
828
Atara Biotherapeutics
ATRA
$77.5M
| $115K | ﹤0.01% |
162
+39
| +32% | +$36.2K |
|
829
AngioDynamics
ANGO
$647M
| $113K | ﹤0.01% |
+5,800
| New | +$120K |
|
830
Editas Medicine
EDIT
$438M
| $113K | ﹤0.01% |
5,160
+1,314
| +34% | +$35.8K |
|
831
NVE Corp
NVEC
$585M
| $113K | ﹤0.01% |
+1,302
| New | +$118K |
|
832
CRISPR Therapeutics
CRSP
$5.19B
| $112K | ﹤0.01% |
3,987
+1,765
| +79% | +$61.4K |
|
|
UCTT
833
Ultra Clean Holdings
UCTT
$3.81B
| $112K | ﹤0.01% |
13,436
+8,414
| +168% | +$82.3K |
|
|
BLUE
834
DELISTED
bluebird bio
BLUE
| $110K | ﹤0.01% |
85
+23
| +37% | +$35.3K |
|
835
Ionis Pharmaceuticals
IONS
$9.51B
| $110K | ﹤0.01% |
2,080
-272
| -12% | -$13.9K |
|
836
Intellia Therapeutics
NTLA
$1.69B
| $110K | ﹤0.01% |
8,381
+2,892
| +53% | +$53.8K |
|
|
CLLS
837
Cellectis
CLLS
$267M
| $109K | ﹤0.01% |
6,545
+1,787
| +38% | +$41.4K |
|
|
AEGN
838
DELISTED
Aegion Corp
AEGN
| $109K | ﹤0.01% |
6,532
+2,875
| +79% | +$57.4K |
|
839
Novartis
NVS
$297B
| $108K | ﹤0.01% |
1,417
-86
| -6% | -$6.69K |
|
840
Forum Energy Technologies
FET
$875M
| $107K | ﹤0.01% |
+1,191
| New | +$180K |
|
841
CONMED
CNMD
$1.49B
| $106K | ﹤0.01% |
1,742
+454
| +35% | +$31.1K |
|
842
Sanofi
SNY
$104B
| $106K | ﹤0.01% |
2,486
-253
| -9% | -$11.2K |
|
|
GRFS
843
Grifois
GRFS
$5.49B
| $105K | ﹤0.01% |
5,770
+1,799
| +45% | +$35.8K |
|
|
LDL
844
DELISTED
Lydall, Inc.
LDL
| $105K | ﹤0.01% |
+5,244
| New | +$143K |
|
845
Camtek
CAMT
$7.21B
| $104K | ﹤0.01% |
+15,413
| New | +$119K |
|
846
Stellantis
STLA
$21.1B
| $104K | ﹤0.01% |
7,358
+3,367
| +84% | +$54.2K |
|
|
HT
847
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $104K | ﹤0.01% |
6,249
| – | – |
|
|
APTS
848
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $102K | ﹤0.01% |
7,157
| – | – |
|
849
Alaunos Therapeutics
TCRT
$4.86M
| $101K | ﹤0.01% |
314
+114
| +57% | +$45.1K |
|
850
Voyager Therapeutics
VYGR
$200M
| $101K | ﹤0.01% |
11,380
+4,559
| +67% | +$58.5K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Mitsubishi UFJ Asset Management held 969 positions worth $3.97B, down 18% from $4.87B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Mitsubishi UFJ Asset Management withdrew a net $143M in Q4 2018, closing 52 positions and reducing 549 holdings. Its most notable exit was Aetna Inc, an estimated $9.02M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Mitsubishi UFJ Asset Management opened a new position in Lamb Weston worth $10.5M.
- Mitsubishi UFJ Asset Management's largest Q4 2018 buy was Lamb Weston: 143,889 shares worth $10.5M.
- Mitsubishi UFJ Asset Management added most to McDonald's in Q4 2018, an estimated $21.2M increase.
- Mitsubishi UFJ Asset Management's biggest Q4 2018 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $32.9M.
- Mitsubishi UFJ Asset Management fully exited Aetna Inc in Q4 2018, selling an estimated $9.02M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 21% of its $3.97B portfolio in Q4 2018.
- Mitsubishi UFJ Asset Management opened 42 new positions and closed 52 in Q4 2018.
- Mitsubishi UFJ Asset Management's portfolio value fell 18% quarter-over-quarter to $3.97B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.